Kezar Life Sciences explores strategic alternatives after FDA setback
Tweet Send to a Friend
Kezar Life Sciences Inc. (NASDAQ: KZR) announced it will explore strategic alternatives after failing to reach agreement with the Food ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


